Last Updated:
Name Designation Appointment Date Status
Savaridoss Lidiyanayagi

Appointed as Director since September 2022

Director 01-Sep-2022 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Bacalt Biotech Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Shruti Ketan Kutmutia

Appointed as Director since September 2022

Director 01-Sep-2022 Current
Kavitha Krishnamoorthy Karimangalam

Appointed as Director since September 2022

Director 01-Sep-2022 Current

People Timeline

Explore the timeline of key personnel in Bacalt Biotech Private Limited's leadership journey.

Loading...
Contact Details
  • Address No 42/1-14,(Flat No S5) Bk Eternity Apts 18Th Cross, 12 A Main, Muthyalanagar, Bangalore Karnataka, 560054, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 560054
  • Country India
  • Website -
Frequently Asked Questions
You can contact Bacalt Biotech Private Limited through their registered address at No 42/1-14,(Flat No S5) Bk Eternity Apts 18Th Cross, 12 A Main, Muthyalanagar, Bangalore Karnataka, 560054, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Bacalt Biotech Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SAVARIDOSS LIDIYANAYAGI
  • SHRUTI KETAN KUTMUTIA
  • KAVITHA KRISHNAMOORTHY KARIMANGALAM
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available